central drugs standard control organisation

MTaI organises high-level meeting with government stakeholders, MediTech industry captains – ET HealthWorld

by
MTaI organises high-level meeting with government stakeholders, MediTech industry captains – ET HealthWorld

New Delhi: The Medical Technology Association of India (MTaI), recently organised a high–level meeting with government stakeholders, and MediTech industry captains. The event was graced by Dr Arunish Chawla, Secretary, Department of Pharmaceuticals (DoP), and Aseem Sahu, Deputy Drugs Controller, Central Drugs Standard Control Organisation (CDSCO). The meeting revolved around India’s prospects and obstacles within … Read more

CDSCO starts probe into Indian-manufactured eye drops leading to infection

by
CDSCO starts probe into Indian-manufactured eye drops leading to infection

The CDSCO has begun investigation against a complaint raised by Sri Lankan Ministry of Health alleging eyedrops manufactured in India cause eye infection | representative image The Central Drugs Standard Control Organisation (CDSCO) has initiated an investigation into a complaint raised by the Sri Lankan Ministry of Health alleging that eyedrops manufactured in India are … Read more

Centre considering testing drugs at govt. laboratories before exporting

by
Centre considering testing drugs at govt. laboratories before exporting

Illustration photo shows various medicine pills in their original packaging | Photo Credit: Reuters Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries. The apex drug regulatory authority, the Central … Read more

Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

by
Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets

Image for representational purposes only. | Photo Credit: The Hindu Bharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at ₹800 (excluding GST) for private markets and ₹325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab … Read more

Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

by
Coronavirus Vaccine For Kids: DCGI grants EUA to Covaxin for 6 to 12 year age group and Corbevax for 5 to 12 Years Age Group

DCGI Approved Corbevax Vaccine for 5 to 12 Years Age Group, Covaxin Vaccine for 6-12 Age Groups: The Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) to Covaxin for use in 6 to 12 years old children. The national drug regulator has asked Covaxin manufacturer Bharat Biotech to submit safety data. … Read more

Covid-19: Zydus Cadila’s ZyCov-D vaccine gets nod for emergency use in India — here’s everything you must know about country’s sixth vaccine

by
Covid-19: Zydus Cadila’s ZyCov-D vaccine gets nod for emergency use in India — here’s everything you must know about country’s sixth vaccine

CDSCO on Friday approved Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use authorisation in adults and children aged 12 years and above India’s drug regulator, Central Drugs Standard Control Organisation (CDSCO), on Friday approved Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use authorisation in adults and children aged 12 years and above. This … Read more

Covid-19: After Oxford vaccine, expert panel recommends conditional nod to Bharat Biotech’s Covaxin

by
Covid-19: After Oxford vaccine, expert panel recommends conditional nod to Bharat Biotech’s Covaxin

Coronavirus vaccine update: After giving its approval to Oxford-AstraZeneca Covid-19 vaccine, the subject expert committee of the Central Drugs Standard Control Organisation(CDSCO) on Saturday gave its nod for Covaxin for the emergence use. According to sources, the panel recommends granting approval for restricted emergency use of Bharat Biotech’s indigenous COVID vaccine Covaxin in India, news … Read more